Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Príomhchruthaitheoir: | Siddika, Khadiza |
---|---|
Rannpháirtithe: | Ahmed, Syeda Maliha |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
Brac University
2024
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/24296 |
Míreanna comhchosúla
-
Targeted therapeutic options in the treatment of Breast Cancer
de réir: Alam, Kazi Tasnuva
Foilsithe / Cruthaithe: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
de réir: Rattry, Faria Rahman
Foilsithe / Cruthaithe: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
de réir: Tania, Umme
Foilsithe / Cruthaithe: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
de réir: Jahan, Nusrat
Foilsithe / Cruthaithe: (2024) -
Molecular biology : genes to proteins /
de réir: Tropp, Burton E.
Foilsithe / Cruthaithe: (2008)